FeedworthyAI
Back to feed
GEN – Genetic Engineering and Biotechnology Newsnews

Backed by $165M, Bionyra Pharma Launches to Advance Inflammatory Disease Biologics

Friday, June 26, 2026Uduak ThomasView original

The company, which emerged from stealth this week, is using the funds to develop and test three therapeutic assets that it licensed from external partners as well as to progress some additional preclinical assets.

The post Backed by $165M, Bionyra Pharma Launches to Advance Inflammatory Disease Biologics appeared first on GEN - Genetic Engineering and Biotechnology News.